RECRUITINGOBSERVATIONAL
SCAPIS 2 Cardio - Vibrometer Based Pulse Wave Analysis and CVD Risk Assessment
About This Trial
This clinical investigation will evaluate a novel contactless technology for assessing arterial stiffness and pulse wave characteristics and explore its potential in assessment of coronary artery disease, aortic stenosis and heart failure, in a population-based sample aged 58-72 years. It will be the first in clinical setting, pilot stage, observational investigation to evaluate the clinical safety, performance and diagnostic accuracy of Cardio P4, a laser-doppler vibrometry (LDV) and microwave radar-based device.
Who May Be Eligible (Plain English)
Who May Qualify:
- Subjects already included in the main / general SCAPIS 2 study at Danderyd Hospital in Stockholm, and of which has also participated in the echocardiography examination
Who Should NOT Join This Trial:
- Patients unable to provide an willing to sign a consent form
Always talk to your doctor about whether this trial is right for you.
Original Eligibility Criteria
View original clinical language
Inclusion Criteria:
* Subjects already included in the main / general SCAPIS 2 study at Danderyd Hospital in Stockholm, and of which has also participated in the echocardiography examination
Exclusion Criteria:
* Patients unable to provide an informed consent
Treatments Being Tested
DIAGNOSTIC_TEST
Coronary Computer Tomography (CCTA)
Use of standard equipment for usual care
OTHER
Laser Doppler Vibrometry and single-lead ECG
Physiological data acquisition equipment
DEVICE
Echocardiography
GE Vivid E95
DEVICE
Pulse Wave Velocity
Arteriograph, Tensiomed, Hungary
Locations (1)
Danderyds Hospital, KFC - Hjärt-kärllaboratoriet
Stockholm, Sweden